New analyses from FIBRONEER™ trials suggest survival benefit with nerandomilast in IPF and PPF
· Financial Post
Not intended for UK and US audiences Read More
Visit sport-newz.biz for more information.
· Financial Post
Visit sport-newz.biz for more information.